3 results
Objectives: • To provide continuing treatment to subjects with SLE who complete HGS1006-C1056 or HGS1006-C1057.• To evaluate the long-term safety and tolerability of belimumab in subjects with SLE.
To determine the acceptance and usability of the TraumaGameplay (TGP) app in individuals who have experienced a traumatic event within the first five days and the staff members of Slachtofferhulp Nederland (Department Amsterdam) who will deliver the…
Primary objective: To evaluate the safety and tolerability of GSK1795091 when administered in combination with either GSK3174998, GSK3359609, orpembrolizumab.Secondary objectives: * To evaluate the antitumor activity of GSK1795091 when administered…